Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

IL-13 pre-treatment of murine peritoneal macrophages increases their anti-Toxoplasma gondii activity induced by lipopolysaccharides.

Authier H, Cassaing S, Bans V, Batigne P, Bessières MH, Pipy B.

Int J Parasitol. 2008 Mar;38(3-4):341-52. Epub 2007 Sep 6.

PMID:
17923133
2.
3.

Interleukin-13 primes iNO synthase expression induced by LPS in mouse peritoneal macrophages.

Authier H, Cassaing S, Coste A, Balard P, Gales A, Berry A, Bans V, Bessières MH, Pipy B.

Mol Immunol. 2008 Jan;45(1):235-43. Epub 2007 Jun 12.

PMID:
17568676
4.

Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production.

Rutschman R, Lang R, Hesse M, Ihle JN, Wynn TA, Murray PJ.

J Immunol. 2001 Feb 15;166(4):2173-7. Erratum in: J Immunol 2001 Apr 1;166(7):4788.

5.
6.

Reduced bactericidal activity and nitric oxide production in metallothionein-deficient macrophages in response to lipopolysaccharide stimulation.

Itoh N, Shibayama H, Kanekiyo M, Namphung D, Nakanishi T, Matsuyama A, Odani T, Tanaka K.

Toxicology. 2005 Dec 15;216(2-3):188-96. Epub 2005 Sep 12.

PMID:
16157437
7.

IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-alpha in host macrophages.

Butcher BA, Kim L, Panopoulos AD, Watowich SS, Murray PJ, Denkers EY.

J Immunol. 2005 Mar 15;174(6):3148-52.

8.
10.

Interleukin-13 neutralization modulates interleukin-13 induced suppression of reactive oxygen species production in peritoneal macrophages in a murine T-cell lymphoma.

Deepak P, Kumar S, Acharya A.

Cell Immunol. 2008 Feb;251(2):72-7. doi: 10.1016/j.cellimm.2008.03.005. Epub 2008 May 23.

PMID:
18501881
11.

A defect in HIV-1 transgenic murine macrophages results in deficient nitric oxide production.

Dickie P, Roberts A, Lee R.

J Leukoc Biol. 2001 Oct;70(4):592-600.

PMID:
11590196
12.

Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis.

Meyer M, Huaux F, Gavilanes X, van den Brûle S, Lebecque P, Lo Re S, Lison D, Scholte B, Wallemacq P, Leal T.

Am J Respir Cell Mol Biol. 2009 Nov;41(5):590-602. doi: 10.1165/rcmb.2008-0155OC. Epub 2009 Feb 24.

PMID:
19244203
13.

Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity.

Bhattacharjee S, Gupta G, Bhattacharya P, Mukherjee A, Mujumdar SB, Pal A, Majumdar S.

J Antimicrob Chemother. 2009 Feb;63(2):317-24. doi: 10.1093/jac/dkn479. Epub 2008 Nov 25.

PMID:
19036753
15.
16.

Macrophage activation: classical versus alternative.

Classen A, Lloberas J, Celada A.

Methods Mol Biol. 2009;531:29-43. doi: 10.1007/978-1-59745-396-7_3.

PMID:
19347309
17.

A sub-inhibitory concentration of amphotericin B enhances candidastatic activity of interferon-gamma- and interleukin-13-treated murine peritoneal macrophages.

Coste A, Linas MD, Cassaing S, Bernad J, Chalmeton S, Séguéla JP, Pipy B.

J Antimicrob Chemother. 2002 May;49(5):731-40.

PMID:
12003965
18.

Chronic estradiol administration in vivo promotes the proinflammatory response of macrophages to TLR4 activation: involvement of the phosphatidylinositol 3-kinase pathway.

Calippe B, Douin-Echinard V, Laffargue M, Laurell H, Rana-Poussine V, Pipy B, Guéry JC, Bayard F, Arnal JF, Gourdy P.

J Immunol. 2008 Jun 15;180(12):7980-8.

19.

Suppressed production of pro-inflammatory cytokines by LPS-activated macrophages after treatment with Toxoplasma gondii lysate.

Lee EJ, Heo YM, Choi JH, Song HO, Ryu JS, Ahn MH.

Korean J Parasitol. 2008 Sep;46(3):145-51. doi: 10.3347/kjp.2008.46.3.145.

20.

Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages.

Tripathi S, Maier KG, Bruch D, Kittur DS.

J Surg Res. 2007 Apr;138(2):209-13. Epub 2007 Feb 8.

PMID:
17291534

Supplemental Content

Support Center